Team:EPF-Lausanne/Our Project/Data

From 2011.igem.org

(Difference between revisions)
(Summary)
(Summary)
Line 5: Line 5:
=== Summary ===
=== Summary ===
-
[[File:EPFL-Summary_drawing.png|right|thumb|350px]]
+
[[File:EPFL-Summary_drawing.png|right|thumb|300px]]
Three components constitute our transcription factor development pipeline. The first is a selection system which lyses cells containing strong matches between a mutated transcription factor and its promoter and allows for the speedy recovery of the relevant DNA. The second component is an ''in vivo'' characterization system that uses two different reporter systems as a way to document the binding affinities of the TetR transcription factor and its promoter pTet. The third component is an ''in vitro'' characterization system called MITOMI that allows high-throughput quantitative analysis of DNA-protein interaction strengths.
Three components constitute our transcription factor development pipeline. The first is a selection system which lyses cells containing strong matches between a mutated transcription factor and its promoter and allows for the speedy recovery of the relevant DNA. The second component is an ''in vivo'' characterization system that uses two different reporter systems as a way to document the binding affinities of the TetR transcription factor and its promoter pTet. The third component is an ''in vitro'' characterization system called MITOMI that allows high-throughput quantitative analysis of DNA-protein interaction strengths.

Revision as of 22:03, 28 October 2011